Phosphoric Acid

Phosphoric Acid

SCHEMBL17061102

N=C(N)N.N=C(N)N.N=C(N)N.O=P([O-])([O-])[O-].O=P([O-])([O-])[O-].[Zn+2].[Zn+2].[Zn+2]

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.38
CA4 P22748 2/20 0.38
CA5A P35218 2/20 0.38
CA5B Q9Y2D0 2/20 0.38
SLC34A1 Q06495 1/20 0.38
LMNA P02545 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phosphoric Acid SCHEMBL17061101 1.00 CA1 (0.38) CA1CA4CA5ACA5BSLC34A1
Phosphoric Acid SCHEMBL29994765 0.92 CA1 (0.38) CA1CA4CA5ACA5BSLC34A1
Phosphoric Acid SCHEMBL11663056 0.92 CA1 (0.38) CA1CA4CA5ACA5BSLC34A1
Phosphoric Acid SCHEMBL11663061 0.92 CA1 (0.38) CA1CA4CA5ACA5BSLC34A1
Phosphoric Acid SCHEMBL28838051 0.92 CA1 (0.38) CA1CA4CA5ACA5BSLC34A1
Phosphoric Acid SCHEMBL11657674 0.89 CA1 (0.36) CA1CA4CA5ACA5BSLC34A1
Phosphoric Acid SCHEMBL11657667 0.89 CA1 (0.36) CA1CA4CA5ACA5BSLC34A1
Phosphoric Acid SCHEMBL28602129 0.89 SLC34A1 (0.44) CA1CA4CA5ACA5BSLC34A1
Guanidine SCHEMBL7193011 0.86 CA1 (0.35) CA1CA4CA5ACA5BSLC34A1
Phosphoric Acid SCHEMBL9442053 0.81 SLC34A1 (0.44) CA1CA4CA5ACA5BSLC34A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104981473-B Azine metal phosphates as flame-retardant materials J.M.休伯有限公司 2021-06-29 CN disclosed
US-9505793-B2 Azine metal phosphates as flame-retardant materials J.M. HUBER CORPORATION (US) 2016-11-29 US disclosed
US-20160137678-A9 AZINE METAL PHOSPHATES AS FLAME-RETARDANT MATERIALS J.M. HUBER CORPORATION 2016-05-19 US disclosed
CN-104981473-A Azine metal phosphates as flame-retardant materials CATANA ADDITIVES GMBH & CO KG 2015-10-14 CN disclosed
US-20150252065-A1 AZINE METAL PHOSPHATES AS FLAME-RETARDANT MATERIALS WEHNER WOLFGANG (DE) 2015-09-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160137678-A9 AZINE METAL PHOSPHATES AS FLAME-RETARDANT MATERIALS MDM4, MTAP, PNP CA1 3393/4885CA4 1386/4885CA5A 350/4885
US-20150252065-A1 AZINE METAL PHOSPHATES AS FLAME-RETARDANT MATERIALS MDM4, MTAP, PNP CA1 3393/4885CA4 1386/4885CA5A 350/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.